Phosphorylation-dependent interaction of SATB1 and PIAS1 directs SUMO-regulated caspase cleavage of SATB1

Molecular and Cellular Biology

Volumn 30, Issue 11, 2010, Pages 2823-2836

  Tan, Joseph Anthony T ^a   Song, Jing ^a,b   Chen, Yuan ^a   Durrin, Linda K ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b BioDuro LLC   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CASPASE; LIGASE; PIAS1 PROTEIN; SPECIAL AT RICH SEQUENCE BINDING PROTEIN 1; SUMO PROTEIN; THREONINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; HUMAN; HUMAN CELL; MUTAGENESIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION;

AMINO ACID SEQUENCE; ANIMALS; CASPASES; CELL LINE; HUMANS; MATRIX ATTACHMENT REGION BINDING PROTEINS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN INHIBITORS OF ACTIVATED STAT; RECOMBINANT FUSION PROTEINS; SEQUENCE ALIGNMENT; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 77952650673     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01603-09     Document Type: Article

References (74)

1. Anckar, J., and L. Sistonen. 2007. SUMO: getting it on. Biochem. Soc. Trans. 35:1409-1413.
2. Aravind, L., and E. V. Koonin. 2000. SAP-a putative DNA-binding motif involved in chromosomal organization. Trends Biochem. Sci. 25:112-114.
3. Braverman, R., B. Bhattacharya, N. Feuerstein, and H. L. Cooper. 1986. Identification and characterization of the nonphosphorylated precursor of pp17, a phosphoprotein associated with phorbol ester induction of growth arrest and monocytic differentiation in HL-60 promyelocytic leukemia cells. J. Biol. Chem. 261:14342-14348.
4. Cormack, B. 1999. Current protocols in molecular biology, vol. 1-4. John Wiley and Sons, Inc., New York, NY.
5. Darimont, B. D., R. L. Wagner, J. W. Apriletti, M. R. Stallcup, P. J. Kushner, J. D. Baxter, R. J. Fletterick, and K. R. Yamamoto. 1998. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12:3343-3356. (Pubitemid 28520983)
6. Desterro, J. M., J. Thomson, and R. T. Hay. 1997. Ubch9 conjugates SUMO but not ubiquitin. FEBS Lett. 417:297-300.
7. Dickinson, L. A., T. Joh, Y. Kohwi, and T. Kohwi-Shigematsu. 1992. A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognition. Cell 70:631-645.
8. Dobreva, G., J. Dambacher, and R. Grosschedl. 2003. SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression. Genes Dev. 17:3048-3061. (Pubitemid 38040769)
9. Duprez, E., A. J. Saurin, J. M. Desterro, V. Lallemand-Breitenbach, K. Howe, M. N. Boddy, E. Solomon, H. de The, R. T. Hay, and P. S. Freemont. 1999. SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J. Cell Sci. 112(part 3):381-393. (Pubitemid 29080660)
10. Everett, R. D., P. Lomonte, T. Sternsdorf, R. van Driel, and A. Orr. 1999. Cell cycle regulation of PML modification and ND10 composition. J. Cell Sci. 112(part 24):4581-4588.
11. Galande, S., L. A. Dickinson, I. S. Mian, M. Sikorska, and T. Kohwi-Shigematsu. 2001. SATB1 cleavage by caspase 6 disrupts PDZ domainmediated dimerization, causing detachment from chromatin early in T-cell apoptosis. Mol. Cell. Biol. 21:5591-5604.
12. Garcia, L., F. Garcia, F. Llorens, M. Unzeta, E. Itarte, and N. Gomez. 2002. PP1/PP2A phosphatases inhibitors okadaic acid and calyculin A block ERK5 activation by growth factors and oxidative stress. FEBS Lett. 523:90-94. (Pubitemid 34786064)
13. Gong, L., T. Kamitani, K. Fujise, L. S. Caskey, and E. T. Yeh. 1997. Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9. J. Biol. Chem. 272:28198-28201.
14. Gotzmann, J., M. Meissner, and C. Gerner. 2000. The fate of the nuclear matrix-associated-region-binding protein SATB1 during apoptosis. Cell Death Differ. 7:425-438. (Pubitemid 30255711)
15. Gross, M., B. Liu, J. Tan, F. S. French, M. Carey, and K. Shuai. 2001. Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells. Oncogene 20:3880-3887. (Pubitemid 32646198)
16. Gross, M., R. Yang, I. Top, C. Gasper, and K. Shuai. 2004. PIASy-mediated repression of the androgen receptor is independent of sumoylation. Oncogene 23:3059-3066. (Pubitemid 38648196)
17. Han, H. J., J. Russo, Y. Kohwi, and T. Kohwi-Shigematsu. 2008. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452:187-193.
18. Hay, R. T. 2005. SUMO: a history of modification. Mol. Cell 18:1-12.
19. Hietakangas, V., J. Anckar, H. A. Blomster, M. Fujimoto, J. J. Palvimo, A. Nakai, and L. Sistonen. 2006. PDSM, a motif for phosphorylation-dependent SUMO modification. Proc. Natl. Acad. Sci. U. S. A. 103:45-50.
20. Itahana, K., H. Mao, A. Jin, Y. Itahana, H. V. Clegg, M. S. Lindstrom, K. P. Bhat, V. L. Godfrey, G. I. Evan, and Y. Zhang. 2007. Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation. Cancer Cell 12:355-366.
21. Iyer, A. K., Y. H. Zhang, and E. R. McCabe. 2007. LXXLL motifs and AF-2 domain mediate SHP (NR0B2) homodimerization and DAX1 (NR0B1)-DAX1A heterodimerization. Mol. Genet. Metab. 92:151-159.
22. Jackson, P. K. 2001. A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases. Genes Dev. 15:3053-3058.
23. Kahyo, T., T. Nishida, and H. Yasuda. 2001. Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol. Cell 8:713-718. (Pubitemid 32946947)
24. Kinoshita, E., E. Kinoshita-Kikuta, H. Ujihara, and T. Koike. 2009. Mobility shift detection of phosphorylation on large proteins using a Phos-tag SDS-PAGE gel strengthened with agarose. Proteomics 9:4098-4101.
25. Kotaja, N., U. Karvonen, O. A. Janne, and J. J. Palvimo. 2002. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol. Cell. Biol. 22:5222-5234.
26. Kumar, P. P., O. Bischof, P. K. Purbey, D. Notani, H. Urlaub, A. Dejean, and S. Galande. 2007. Functional interaction between PML and SATB1 regulates chromatin-loop architecture and transcription of the MHC class I locus. Nat. Cell Biol. 9:45-56.
27. Lamkanfi, M., N. Festjens, W. Declercq, T. Vanden Berghe, and P. Vandenabeele. 2007. Caspases in cell survival, proliferation and differentiation. Cell Death Differ. 14:44-55. (Pubitemid 44911893)
28. Lee, H., J. C. Quinn, K. V. Prasanth, V. A. Swiss, K. D. Economides, M. M. Camacho, D. L. Spector, and C. Abate-Shen. 2006. PIAS1 confers DNA-binding specificity on the Msx1 homeoprotein. Genes Dev. 20:784-794.
29. Lin, J. Y., T. Ohshima, and K. Shimotohno. 2004. Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53. FEBS Lett. 573:15-18.
30. Liu, B., M. Gross, J. ten Hoeve, and K. Shuai. 2001. A transcriptional corepressor of Stat1 with an essential LXXLL signature motif. Proc. Natl. Acad. Sci. U. S. A. 98:3203-3207.
31. Liu, B., and K. Shuai. 2008. Regulation of the sumoylation system in gene expression. Curr. Opin. Cell Biol. 20:288-293.
32. Liu, B., Y. Yang, V. Chernishof, R. R. Loo, H. Jang, S. Tahk, R. Yang, S. Mink, D. Shultz, C. J. Bellone, J. A. Loo, and K. Shuai. 2007. Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity. Cell 129:903-914.
33. Luthi, A. U., and S. J. Martin. 2007. The CASBAH: a searchable database of caspase substrates. Cell Death Differ. 14:641-650.
34. McInerney, E. M., D. W. Rose, S. E. Flynn, S. Westin, T. M. Mullen, A. Krones, J. Inostroza, J. Torchia, R. T. Nolte, N. Assa-Munt, M. V. Milburn, C. K. Glass, and M. G. Rosenfeld. 1998. Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev. 12:3357-3368.
35. Megidish, T., J. H. Xu, and C. W. Xu. 2002. Activation of p53 by protein inhibitor of activated Stat1 (PIAS1). J. Biol. Chem. 277:8255-8259.
36. Melchior, F., M. Schergaut, and A. Pichler. 2003. SUMO: ligases, isopeptidases and nuclear pores. Trends Biochem. Sci. 28:612-618.
37. Minty, A., X. Dumont, M. Kaghad, and D. Caput. 2000. Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. J. Biol. Chem. 275:36316-36323.
38. Mothe, I., and E. Van Obberghen. 1996. Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action. J. Biol. Chem. 271:11222-11227.
39. Muller, S., M. Berger, F. Lehembre, J. S. Seeler, Y. Haupt, and A. Dejean. 2000. c-Jun and p53 activity is modulated by SUMO-1 modification. J. Biol. Chem. 275:13321-13329.
40. Nakagomi, K., Y. Kohwi, L. A. Dickinson, and T. Kohwi-Shigematsu. 1994. A novel DNA-binding motif in the nuclear matrix attachment DNA-binding protein SATB1. Mol. Cell. Biol. 14:1852-1860.
41. Nakayama, Y., I. S. Mian, T. Kohwi-Shigematsu, and T. Ogawa. 2005. A nuclear targeting determinant for SATB1, a genome organizer in the T cell lineage. Cell Cycle 4:1099-1106. (Pubitemid 41365370)
42. Nie, H., S. D. Maika, P. W. Tucker, and P. D. Gottlieb. 2005. A role for SATB1, a nuclear matrix association region-binding protein, in the development of CD8SP thymocytes and peripheral T lymphocytes. J. Immunol. 174:4745-4752. (Pubitemid 40504556)
43. Okubo, S., F. Hara, Y. Tsuchida, S. Shimotakahara, S. Suzuki, H. Hatanaka, S. Yokoyama, H. Tanaka, H. Yasuda, and H. Shindo. 2004. NMR structure of the N-terminal domain of SUMO ligase PIAS1 and its interaction with tumor suppressor p53 and A/T-rich DNA oligomers. J. Biol. Chem. 279:31455-31461.
44. Olson, N. E., J. D. Graves, G. L. Shu, E. J. Ryan, and E. A. Clark. 2003. Caspase activity is required for stimulated B lymphocytes to enter the cell cycle. J. Immunol. 170:6065-6072.
45. Palvimo, J. J. 2007. PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription. Biochem. Soc. Trans. 35:1405-1408.
46. Pavan Kumar, P., P. K. Purbey, C. K. Sinha, D. Notani, A. Limaye, R. S. Jayani, and S. Galande. 2006. Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo. Mol. Cell 22:231-243.
47. Plevin, M. J., M. M. Mills, and M. Ikura. 2005. The LxxLL motif: a multifunctional binding sequence in transcriptional regulation. Trends Biochem. Sci. 30:66-69.
48. Purbey, P. K., S. Singh, P. P. Kumar, S. Mehta, K. N. Ganesh, D. Mitra, and S. Galande. 2008. PDZ domain-mediated dimerization and homeodomain-directed specificity are required for high-affinity DNA binding by SATB1. Nucleic Acids Res. 36:2107-2122.
49. Purbey, P. K., S. Singh, D. Notani, P. P. Kumar, A. S. Limaye, and S. Galande. 2009. Acetylation-dependent interaction of SATB1 and CtBP1 mediates transcriptional repression by SATB1. Mol. Cell. Biol. 29:1321-1337.
50. Razeto, A., V. Ramakrishnan, C. M. Litterst, K. Giller, C. Griesinger, T. Carlomagno, N. Lakomek, T. Heimburg, M. Lodrini, E. Pfitzner, and S. Becker. 2004. Structure of the NCoA-1/SRC-1 PAS-B domain bound to the LXXLL motif of the STAT6 transactivation domain. J. Mol. Biol. 336:319-329.
51. Rytinki, M. M., S. Kaikkonen, P. Pehkonen, T. Jaaskelainen, and J. J. Palvimo. 2009. PIAS proteins: pleiotropic interactors associated with SUMO. Cell. Mol. Life Sci. 66:3029-3041.
52. Sachdev, S., L. Bruhn, H. Sieber, A. Pichler, F. Melchior, and R. Grosschedl. 2001. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev. 15:3088-3103. (Pubitemid 33115674)
53. Savkur, R. S., and T. P. Burris. 2004. The coactivator LXXLL nuclear receptor recognition motif. J. Pept. Res. 63:207-212.
54. Schmidt, D., and S. Muller. 2002. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc. Natl. Acad. Sci. U. S. A. 99:2872-2877.
55. Seeler, J. S., and A. Dejean. 2003. Nuclear and unclear functions of SUMO. Nat. Rev. Mol. Cell Biol. 4:690-699.
56. Seo, J., M. M. Lozano, and J. P. Dudley. 2005. Nuclear matrix binding regulates SATB1-mediated transcriptional repression. J. Biol. Chem. 280:24600-24609.
57. Sharrocks, A. D. 2006. PIAS proteins and transcriptional regulation-more than just SUMO E3 ligases? Genes Dev. 20:754-758.
58. Shen, T. H., H. K. Lin, P. P. Scaglioni, T. M. Yung, and P. P. Pandolfi. 2006. The mechanisms of PML-nuclear body formation. Mol. Cell 24:331-339.
59. Shuai, K., and B. Liu. 2005. Regulation of gene-activation pathways by PIAS proteins in the immune system. Nat. Rev. Immunol. 5:593-605.
60. Song, J., L. K. Durrin, T. A. Wilkinson, T. G. Krontiris, and Y. Chen. 2004. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc. Natl. Acad. Sci. U. S. A. 101:14373-14378.
61. Steidl, U., C. Steidl, A. Ebralidze, B. Chapuy, H. J. Han, B. Will, F. Rosenbauer, A. Becker, K. Wagner, S. Koschmieder, S. Kobayashi, D. B. Costa, T. Schulz, K. B. O'Brien, R. G. Verhaak, R. Delwel, D. Haase, L. Trumper, J. Krauter, T. Kohwi-Shigematsu, F. Griesinger, and D. G. Tenen. 2007. A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia. J. Clin. Invest. 117:2611-2620.
62. Suzuki, R., H. Shindo, A. Tase, Y. Kikuchi, M. Shimizu, and T. Yamazaki. 2009. Solution structures and DNA binding properties of the N-terminal SAP domains of SUMO E3 ligases from Saccharomyces cerevisiae and Oryza sativa. Proteins 75:336-347.
63. Tan, J. A., S. H. Hall, K. G. Hamil, G. Grossman, P. Petrusz, and F. S. French. 2002. Protein inhibitors of activated STAT resemble scaffold attachment factors and function as interacting nuclear receptor coregulators. J. Biol. Chem. 277:16993-17001.
64. Tan, J. A., Y. Sun, J. Song, Y. Chen, T. G. Krontiris, and L. K. Durrin. 2008. SUMO conjugation to the matrix attachment region-binding protein, special AT-rich sequence-binding protein-1 (SATB1), targets SATB1 to promyelocytic nuclear bodies where it undergoes caspase cleavage. J. Biol. Chem. 283:18124-18134.
65. Tatham, M. H., E. Jaffray, O. A. Vaughan, J. M. Desterro, C. H. Botting, J. H. Naismith, and R. T. Hay. 2001. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J. Biol. Chem. 276:35368-35374.
66. Thompson, P. M., T. Gotoh, M. Kok, P. S. White, and G. M. Brodeur. 2003. CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system. Oncogene 22:1002-1011.
67. van den Akker, E., S. Ano, H. M. Shih, L. C. Wang, M. Pironin, J. J. Palvimo, N. Kotaja, O. Kirsh, A. Dejean, and J. Ghysdael. 2005. FLI-1 functionally interacts with PIASxalpha, a member of the PIAS E3 SUMO ligase family. J. Biol. Chem. 280:38035-38046.
68. Weil, R., C. Laurent-Winter, and A. Israel. 1997. Regulation of IkappaBbeta degradation. Similarities to and differences from IkappaBalpha. J. Biol. Chem. 272:9942-9949.
69. Yamaguchi, H., M. Tateno, and K. Yamasaki. 2006. Solution structure and DNA-binding mode of the matrix attachment region-binding domain of the transcription factor SATB1 that regulates the T-cell maturation. J. Biol. Chem. 281:5319-5327.
70. Yamasaki, K., T. Akiba, T. Yamasaki, and K. Harata. 2007. Structural basis for recognition of the matrix attachment region of DNA by transcription factor SATB1. Nucleic Acids Res. 35:5073-5084. (Pubitemid 47394192)
71. Yang, S. H., A. Galanis, J. Witty, and A. D. Sharrocks. 2006. An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO J. 25:5083-5093.
72. Yang, S. H., E. Jaffray, R. T. Hay, and A. D. Sharrocks. 2003. Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity. Mol. Cell 12:63-74.
73. Yasui, D., M. Miyano, S. Cai, P. Varga-Weisz, and T. Kohwi-Shigematsu. 2002. SATB1 targets chromatin remodelling to regulate genes over long distances. Nature 419:641-645.
74. Zor, T., R. N. De Guzman, H. J. Dyson, and P. E. Wright. 2004. Solution structure of the KIX domain of CBP bound to the transactivation domain of c-Myb. J. Mol. Biol. 337:521-534.